Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

Further to our intimation dated October 4, 2021 in this regard, and in terms of requirement of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that the Board of Directors, based on the recommendations of the Audit Committee and the Committee of Independent Directors, has considered and approved a Composite Scheme of Amalgamation and Arrangement (the 'Scheme') presented under Section 230 to 232 read with other applicable provisions of the Companies Act, 2013 ('the Act') and the Rules framed thereunder. Further the Board has given authorisation to file the Scheme along with relevant disclosures, documents, certifications, and undertakings with the stock exchange. Disclosure in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is enclosed herewith as Annexure 1.
11-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015 Regarding Planned Partial Shutdown Towards Implementation Of Capacity Enhancement Measures For Vitamin D3 Crystals At Dahej Facility

Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby inform you that Fermenta Biotech Limited (FBL) will be taking a planned partial shutdown of its manufacturing facility at Dahej to carry out capacity increasing measures for Vitamin D3 crystals with effect from today, 5th October 2021 for an estimated period of 15 days, until 20th October 2021. Following the previous shutdown in April 2019, which was successfully completed to increase capacity of Vitamin D3 intermediates, the current shutdown is being taken for increasing Vitamin D3 crystals' capacity. Post completion, FBL's production capacity of Vitamin D3 crystals will increase by approximately 25%. This initiative is part of FBL's capacity enhancement strategy to meet the expected increase in peak demand for Vitamin D3 crystals under the current circumstances. This is for your information and records please.
05-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Intimation Of The Board Meeting To Consider The Composite Scheme Of Amalgamation And Arrangement

Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2021 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, October 11, 2021, inter alia, to consider and approve the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited (Transferor Company 1) and Aegean Properties Limited (Transferor Company 2) and Fermenta Biotech Limited (Transferee Company). This is for your information and record.
04-10-2021
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading, BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window and further to our earlier intimation to insiders dated March 26, 2021 relating to closure of trading window from the end of every quarter for all quarters ending on June 30, September 30, December 31 and March 31, it is hereby notified that the 'Trading Window' (period for trading in Company's securities) will be closed with effect from October 01, 2021 till 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2021, as may be approved at the concerned Board Meeting.
29-09-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Thursday, September 30, 2021, to discuss the investor presentation for August 2021. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
29-09-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Wednesday, September 29, 2021, to discuss the investor presentation for August 2021. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
28-09-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Thursday, September 23, 2021, to discuss the investor presentation for August 2021. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
22-09-2021
Bigul

Fermenta Biotech Ltd - 506414 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Fermenta Biotech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
04-09-2021
Bigul

Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Pursuant to Regulation 44 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the results of remote e-voting (including ballot forms and electronic voting at the Annual General Meeting) on all the resolutions set out in the notice of the 69th Annual General Meeting of the Company held on September 3, 2021 through Video Conferencing/Other Audio Visual Means. Kindly take the same on record.
03-09-2021
Bigul

Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Submission of voting results of Ballot process and Remote E-voting under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with the Scrutinizer''s report
03-09-2021
Next Page
Close

Let's Open Free Demat Account